Reduction of insulin resistance in HepG2 cells by knockdown of LITAF expression in human THP-1 macrophages

Abstract

The molecular mechanism by which obesity induces insulin resistance is not completely understood. The aim of this study was to determine how lipopolysaccharide-induced tumor necrosis-α factor (LITAF) influenced obesity-induced insulin resistance using a cellular co-culture system. The cells were divided into 3 groups: palmitic acid (PA) stimulation group, LITAF small interfering RNA (siRNA) group and untreated (NC) group. The LITAF siRNA was used for knockdown of LITAF expression in human THP-1 macrophages. The expression levels of LITAF, IRS-2, IRS-2Tyr465, PI3K, and GLUT2 in each group were measured by using quantitative reverse transcriptase real-time polymerase chain reaction and Western blotting. The expression of LITAF was much higher in the PA group than in the siRNA and NC groups (*P<0.05); meanwhile, the expression of IRS-2, IRS-2Tyr465, PI3K, and GLUT2 was much lower in the PA group than in the NC group (*P<0.05); however, IRS-2, IRS-2Tyr465, PI3K, and GLUT2 had much higher expression in the siRNA group than in the PA group (*P<0.05). It is concluded that PA can induce insulin resistance in liver cells and knockdown of LITAF expression can reduce insulin resistance in liver cells, suggesting LITAF may regulate the insulin signal transduction pathway involved in obesity-induced insulin resistance.

Keywords

diabetes / obesity / insulin resistance / inflammation / lipopolysaccharide-induced tumor necrosis-α factor

References

[1] ShoelsonS.E., LeeJ., GoldfineA.B.. Inflammation and insulin resistance. J Clin Invest, 2006, 116(8): 1793-1801

[2] MyokaiF., TakashibaS., LeboR., et al.. A novel lipopolysaccharide-induced transcription factor regulating tumor necrosis factor alpha gene expression: molecular cloning, sequencing, characterization, and chromosomal assignment. Proc Natl Acad Sci USA, 1999, 96(3): 4518-4523

[3] TangX., MetzgerD., LeemanS., et al.. LPS-induced TNF-alpha factor (LITAF)-deficient mice express reduced LPS-induced cytokine: Evidence for LI-TAF-dependent LPS signaling pathways. Proc Natl Acad Sci USA, 2006, 103(4): 13 777-13 782

[4] KosakaC., MasudaJ., ShimokadoK., et al.. Interferon-gamma suppresses PDGF production from THP-1 cells and blood monocyte-derived macrophages. Atherosclerosis, 1992, 97(4): 75-87

[5] DietzeD., KoenenM., RohrigK., et al.. Impairment of insulin signaling in human skeletal muscle cells by co-culture with human adipocytes. Diabetes, 2002, 51(4): 2369-2376

[6] ShoelsonS.E., HerreroL., NaazA.. Obesity, inflammation, and insulin resistance. Gastroenterology, 2007, 132(2): 2169-2180

[7] TangX., MarcianoD.L., LeemanS.E., et al.. LPS induces the interaction of a transcription factor, LPS-induced TNF-alpha factor, and STAT6(B) with effects on multiple cytokines. Proc Natl Acad Sci USA, 2005, 102(6): 5132-5137

[8] Ji OzinskyA., UnderhillD.M., FontenotJ.D., et al.. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci USA, 2000, 97(1): 13 766-13 771

[9] PoltorakA., HeX., SmirnovaI., et al.. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science, 1998, 282(3): 2085-2088

[10] ElbashirS.M., HarborthJ., LendeckelW., et al.. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature, 2001, 411(7): 494-498

[11] Le RoithD., ZickY.. Recent advances in our under-standing of insulin action and insulin resistance. Diabetes Care, 2001, 24(8): 588-597

[12] PazK., HemiR., LeRoithD., et al.. A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J Biol Chem, 1997, 272(4): 29 911-29 918

[13] HotamisligilG.S.. Inflammatory pathways and insulin action. Int J Obes Relat Metab Disord, 2003, 27(Suppl3): S53-S55

[14] WangM., TafuriS.. Modulation of PPARgamma activity with pharmaceutical agents: treatment of insulin resistance and atherosclerosis. J Cell Biochem, 2003, 89(1): 38-47